Latest News Archive
Please select Category, Year, and then Month to display items
03 March 2021
|
Story Giselle Baillie
|
Photo Supplied
_web.jpg?sfvrsn=987e6620_1 "NJ van Merwe Read More (1)_web")
Residence members who led the project, included:
Bohlokwa Rantja, the Residence Prime, and Transformation Committee members Nsuku Mutemela, Ofentse Motlakeng, Phindile Tjale, Madinku Mabala, Mmapopi Motshoso, Karabo Shuping, and Tagane Sekete.
The University of the Free State (UFS) Council approved and adopted Lehakwe House as the new name for the
NJ van der Merwe residence on the Bloemfontein Campus. The approval on 26 November 2020 followed a lengthy process of deliberation, consultation, and public engagement that has taken place since November 2019 and is aligned with the UFS Policy on Naming and Renaming. The name-change process was initiated by the Prime and Transformation Committee of the residence, guided by the
Unit for Institutional Change and Social Justice and supported by a multi-stakeholder committee representative of the residence, the Housing and Residence Affairs Office, the Department of Student Affairs, the Student Representative Council, and alumni.
Lehakwe – a precious gem
Following a lengthy evaluation process of the names submitted through a public voting and recommendation platform in July 2020, ‘Lehakwe’ – a Sesotho word referring to a ‘precious gem’ – emerged as the front runner. As many current and past members of the residence attest, this womxn’s residence has come to occupy a significant space within the hearts and minds of UFS students and the UFS community, given that its spirit has always been closely aligned with the constitutional values of dignity, equality, and freedom and with the human values of ubuntu. In this vein, the new name of ‘Lehakwe’ presents a consolidation of constitutional and university values into the day-to-day thinking, learning, living, and legacy spaces of students, as well as everyone who interacts and engages with the UFS.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”